Welcome to the Charing Cross Hospital Trophoblast Disease Service

On this web site we hope to give an introduction to molar pregnancies and gestational trophoblast disease that will be of value to our patients, referring medical teams and other interested readers and health professionals.

All forms of gestational trophoblast diseases are rare and we are fortunate in the UK to have a national service for their follow up and treatment. The centre at Charing Cross was established by the Department of Health in 1973 and has treated over 2500 patients with the various forms of trophoblast disease giving us the largest experience of this disease worldwide.

From the menus to the side you can get a whole range of information including the practicalities of follow-up and hCG monitoring after a molar pregnancy, what to expect if you need admission to Charing Cross for treatment, the results of the most recent research and publications from the unit and also a link to our patients forum to share experiences and offer others support.The service also has a counsellor available to patients registered at CXH and their families.


June 2017 

From 1st July 2017, for women with a single molar pregnancy, we will no longer request hCG at 6 and 10 weeks after any future pregnancies. New data analysis shows that the risk of choriocarcinoma developing is <1:4000. We will continue to offer post-partum follow-up for women with multiple moles and those treated with chemotherapy. This change in practice will be rolled out across the Charing Cross (London) and Weston Park (Sheffield) sites.

Mummy’s Star launches it’s new campaign for ‘Cancer and Pregnancy Awareness Week 2017’, click here to view their press release. 

Cancer and Pregnancy Awareness Week

Web site designed by Paul Littlefield